The Canadian Antibiotic Treatment Guidance, a new resource for prescribers supported by the Public Health Agency of Canada, is now available on the Firstline® platform. This guidance was developed by the Association of Medical Microbiology and Infectious Disease (AMMI) Canada, using a rigorous, evidence-based methodology. These recommendations promote judicious antibiotic use for the management of common infections in primary care.
This initial release focuses on respiratory tract infections. By downloading the guidance now, clinicians can begin adopting best practices to support more effective care for our patients and communities. Additional treatment guidance for other syndromes will be added over time, building on this foundation to promote consistent, evidence-based antibiotic prescribing across Canada.
"The Government of Canada is proud to be working with our partners to develop evidence-based national antimicrobial prescribing guidelines and make them easily accessible to physicians and healthcare prescribers at point-of-care leveraging Canadian digital innovation. This will be a key tool in ensuring the appropriate and responsible use of antibiotics for humans and contribute to the overall action against antimicrobial resistance.”
The Honourable Mark Holland, Minister of Health of Canada
Read more about the five-year action plan (2023 to 2027) to coordinate an accelerated response to address antimicrobial resistance (AMR), one of the major health threats of our time.
Read More
AMMI Canada is using a robust methodological framework reviewing systematic reviews and meta-analyses and evaluating the quality of evidence using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach.
Read More
As stakeholders in the Canadian healthcare landscape, we kindly ask you to help promote and encourage the use of this guidance. A toolkit to support sharing and dissemination is available for download.
Download Now
"Firstline is proud to collaborate with both AMMI Canada and the Government of Canada in the development and dissemination of the Canadian Antibiotic Treatment Guidance. This initiative delivers an important milestone in Canada’s fight against antimicrobial resistance. By combining the Firstline platform with the clinical expertise of AMMI Canada and the leadership of the Public Health Agency of Canada, every healthcare provider in Canada now has timely access to national, evidence-based antibiotic guidance. This tool will support better patient outcomes and judicious antibiotic use, helping protect the efficacy of these essential medicines for generations of Canadians."
Dr. Ariana Saatchi, PhD, Firstline
